Total submissions: 13
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Baylor Genetics | RCV000191056 | SCV000245445 | likely benign | Autosomal recessive inherited pseudoxanthoma elasticum | 2015-06-29 | criteria provided, single submitter | clinical testing | This variant was found once in our laboratory in trans with a pathogenic variant [R518X] in a 39-year-old male with hereditary anemia, angioid streaks on retina, possible pseudoxanthoma elasticum, fatigue, chronic joint pain. However, variant is common, and we have identified homozygotes who do not have features of PXE. |
PXE International | RCV000191056 | SCV000588935 | benign | Autosomal recessive inherited pseudoxanthoma elasticum | 2021-03-01 | criteria provided, single submitter | research | |
Gene |
RCV000132642 | SCV001937019 | benign | not provided | 2015-03-03 | criteria provided, single submitter | clinical testing | This variant is associated with the following publications: (PMID: 19726431, 27884173, 11536079, 16086317, 19339160, 33144682) |
Genome- |
RCV002253238 | SCV002524241 | benign | Arterial calcification, generalized, of infancy, 2 | 2021-12-05 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV000191056 | SCV002524242 | benign | Autosomal recessive inherited pseudoxanthoma elasticum | 2021-12-05 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV002253237 | SCV002524243 | benign | Pseudoxanthoma elasticum, forme fruste | 2021-12-05 | criteria provided, single submitter | clinical testing | |
Fulgent Genetics, |
RCV002492516 | SCV002796738 | benign | Autosomal recessive inherited pseudoxanthoma elasticum; Pseudoxanthoma elasticum, forme fruste; Arterial calcification, generalized, of infancy, 2 | 2021-09-29 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV004019749 | SCV004910917 | benign | Inborn genetic diseases | 2022-03-01 | criteria provided, single submitter | clinical testing | This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Breakthrough Genomics, |
RCV000132642 | SCV005213414 | likely benign | not provided | criteria provided, single submitter | not provided | ||
Department of Ophthalmology and Visual Sciences Kyoto University | RCV000132642 | SCV000172593 | probable-non-pathogenic | not provided | no assertion criteria provided | not provided | Converted during submission to Likely benign. | |
Diagnostic Laboratory, |
RCV001528636 | SCV001740690 | benign | not specified | no assertion criteria provided | clinical testing | ||
Clinical Genetics, |
RCV001528636 | SCV001920712 | benign | not specified | no assertion criteria provided | clinical testing | ||
Genome Diagnostics Laboratory, |
RCV000132642 | SCV001931956 | likely benign | not provided | no assertion criteria provided | clinical testing |